• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    ACADIA Pharmaceuticals Inc. (ACAD)

    -NasdaqGS
    35.61 Up 0.71(2.03%) May 27, 4:00PM EDT
    |After Hours : 35.60 Down 0.01 (0.03%) May 27, 6:43PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 4   17   39   1  
    Cost of Revenue -   -   -   -  
    Gross Profit 4   17   39   1  
    Operating Expenses
    Research Development22,775  20,466  18,729  18,379  
    Selling General and Administrative27,491  25,116  20,308  21,119  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (50,262) (45,565) (38,998) (39,497)
    Income from Continuing Operations
    Total Other Income/Expenses Net500  111  92  119  
    Earnings Before Interest And Taxes(49,762)(45,454)(38,906)(39,378)
    Interest Expense -   -   -   -  
    Income Before Tax(49,762)(45,454)(38,906)(39,378)
    Income Tax Expense -  330   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(49,762)(45,784)(38,906)(39,378)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (49,762) (45,784) (38,906) (39,378)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (49,762) (45,784) (38,906) (39,378)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.